CharlieKey takeaways from your favorite podcasts
← 8 November 2026Y Combinator

Is AI Now Good Enough To Cure Cancer? | YC Paper Club

AI for biology is reaching a tipping point: cheap sequencing makes cancer a per-patient data problem, agents act as research labs, and DNA language models are steerable by prompting and design loops.

Watch on YouTube ↗

Word for word

One of the biggest reasons for failure in the clinic is actually clinical efficacy. One way to interpret that is we are very bad at predicting what is going to work in a human being. And the reason for that is we just don't have very good models that are able to translate to actual human phenotypes, to actual biological phenotypes. We've gotten very good at designing molecules. We've gotten very good at binding to targets once they've been identified, but we are still not very good at identifying the targets themselves that we should be going after.
★ In the digest▶ 33:19
DNA is a language, although it was written through this process of natural selection. So DNA, this genotype of an organism, encodes the RNAs and the proteins that go on through complex biological mechanisms to give rise to complex phenotypes, like whether you're sick or how tall you are. And then natural selection acts on phenotypes, changing what DNA survives and what is observed.
We often don't have the amount of labeled data that we need to fine-tune for many design tasks in biology. So this paradigm of few-shot prompting can be quite powerful for this reason, where we might not have tons of labeled data. We might only have a handful of examples, and we are able to prompt Evo 2.

Do more with Charlie

Free — sign in with your email, no password.